Oral Micronized Progesterone Cost in Hawaii (2026): Prices, Insurance, and Savings

Prescription access and medication affordability image for Oral Micronized Progesterone Cost in Hawaii (2026): Prices, Insurance, and Savings

At a glance

  • Brand Prometrium manufacturer list price / $180 per month
  • Hawaii average retail cash-pay (generic) / $45 per month
  • Compounded progesterone via 503A pharmacy / approximately $25 per month
  • Hawaii Medicaid coverage for HRT indication / not covered
  • Compounded progesterone legality in Hawaii / legal via 503A pharmacies
  • Telehealth prescribing in Hawaii / permitted
  • Standard dosing / 100 mg or 200 mg oral capsule, nightly or cyclic
  • FDA-approved indications / secondary amenorrhea and endometrial protection in HRT
  • Generic availability / yes, multiple manufacturers
  • Discount programs / manufacturer savings cards and GoodRx-type coupons accepted statewide

What Does Oral Micronized Progesterone Cost in Hawaii?

Generic oral micronized progesterone averages $45 per month at Hawaii retail pharmacies in 2026, while brand-name Prometrium carries a manufacturer list price of $180 per month. Compounded progesterone from a licensed 503A pharmacy costs roughly $25 per month, making it the lowest-cost option for women paying out of pocket.

These prices matter because progesterone is a long-term medication for most users. The FDA-approved prescribing information for Prometrium specifies two indications: secondary amenorrhea (400 mg daily for 10 days) and prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens (200 mg daily for 12 sequential days per 28-day cycle, or 200 mg nightly for continuous regimens) [1]. At $45 per month generic pricing, annual out-of-pocket spend totals approximately $540 without insurance.

Price variation across Oahu, Maui, and the Big Island runs about 15% to 20% between pharmacies. Costco and Walmart tend to anchor the lower end near $35 to $40 for a 30-count supply of 100 mg capsules. Independent pharmacies on the neighbor islands sometimes charge $55 to $60, driven by higher distribution costs. The Endocrine Society's 2015 clinical practice guideline on menopause management recommends micronized progesterone over synthetic progestins for endometrial protection based on its safety profile, making cost transparency especially relevant for the thousands of Hawaii women on HRT [2].

Brand vs. Generic vs. Compounded: Price Breakdown

The three formulations available in Hawaii sit at distinct price points, and the clinical differences between them are smaller than the cost gap suggests. Generic micronized progesterone capsules (100 mg and 200 mg) contain the same USP-grade progesterone in peanut oil suspension as brand Prometrium, per FDA bioequivalence standards [3].

Brand Prometrium at $180 per month reflects the manufacturer (originally Solvay, now AbbVie) list price. Few patients pay this amount. Most insured patients with formulary coverage see copays of $10 to $35. The generic, priced at $45 cash, became widely available after patent expiration and carries an AB-rated bioequivalence designation from the FDA.

Compounded progesterone from a 503A pharmacy, at roughly $25 per month, uses bulk USP progesterone powder formulated into capsules on-site. The FDA's guidance on 503A compounding permits this practice when a prescriber writes a patient-specific prescription [4]. Compounded formulations lack the FDA-reviewed bioequivalence testing of manufactured generics, which is a tradeoff patients should discuss with their provider.

One clinical consideration: the PEPI Trial (Postmenopausal Estrogen/Progestin Interventions), a landmark randomized controlled study published in JAMA with 875 women, demonstrated that oral micronized progesterone 200 mg for 12 days per cycle provided endometrial protection comparable to medroxyprogesterone acetate while preserving the HDL benefit of estrogen therapy [5]. That trial is a primary reason clinicians favor micronized progesterone today. Whether patients choose brand, generic, or compounded, the goal is the same 200 mg dose the PEPI Trial validated.

Does Hawaii Medicaid Cover Oral Micronized Progesterone?

Hawaii Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection on hormone replacement therapy. This means the roughly 380,000 Hawaii residents enrolled in Medicaid-managed care plans through HMSA, Kaiser, or AlohaCare must pay out of pocket for this specific indication.

Coverage may exist for the secondary amenorrhea indication in reproductive-age women, as that falls under a different diagnostic category. The distinction is clinical coding. An ICD-10 code of N91.1 (secondary amenorrhea) may trigger coverage, while an E28.3 or related menopausal code paired with Z79.890 (long-term HRT) typically does not. Patients should verify with their managed care plan before filling.

The AACE/ACE 2017 guidelines on menopause recommend that all women with an intact uterus who use systemic estrogen therapy receive adequate progestogen, calling it "mandatory" for endometrial safety [6]. This recommendation makes the Medicaid coverage gap clinically significant. Women who cannot afford progesterone may skip it, raising their risk of endometrial hyperplasia, which the WHI observational study documented at 20% to 30% after 3 to 5 years of unopposed estrogen [7].

For Medicaid enrollees, the $25 compounded option or pharmacy discount cards represent practical workarounds. Some community health centers in Hawaii also carry 340B-priced medications that may reduce cost further.

Which Insurance Plans Cover Progesterone in Hawaii?

Most commercial insurance plans available through the Hawaii Prepaid Health Care Act cover generic oral micronized progesterone with standard formulary copays ranging from $10 to $35 per month. Hawaii's unique employer mandate, which requires coverage for employees working 20 or more hours per week, means a larger share of the state's workforce has drug benefits compared to the national average.

HMSA (Hawaii Medical Service Association), the state's dominant insurer covering roughly 50% of the commercially insured population, lists generic micronized progesterone on its preferred formulary. Kaiser Permanente Hawaii similarly covers the generic on its formulary. Brand Prometrium typically requires prior authorization or sits on a non-preferred tier with higher copays of $50 to $75.

The North American Menopause Society's 2022 position statement on HRT identifies micronized progesterone as the preferred progestogen for most women, noting its favorable cardiovascular and breast safety profile relative to synthetic progestins [8, 9]. Citing these guideline recommendations in a prior authorization appeal can help when coverage is denied. Prescription drug benefits through plans compliant with the ACA essential health benefits framework are required to cover at least one form of each drug class, and progesterone capsules typically satisfy the progestogen requirement [10].

Military families using TRICARE in Hawaii, including those stationed at Joint Base Pearl Harbor-Hickam and Schofield Barracks, can fill generic progesterone at military pharmacies for zero copay, or at retail network pharmacies for $14 (generic tier).

Is Compounded Progesterone Legal in Hawaii?

Compounded progesterone is legal in Hawaii when dispensed by a pharmacy operating under a valid 503A license. Hawaii follows the federal framework established under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding by state-licensed pharmacies when a prescriber writes an individualized prescription [11].

Several compounding pharmacies operate across the Hawaiian islands, with the highest concentration on Oahu. Patients on Maui, Kauai, and the Big Island can also access compounded progesterone, though some may need to use mail-order compounding from Oahu-based pharmacies or mainland 503A pharmacies licensed to ship to Hawaii.

The $25 per month price point for compounded progesterone reflects the lower raw material cost of USP-grade progesterone powder versus the manufacturing, packaging, and regulatory overhead of FDA-approved products. A 2019 pharmacokinetic study published in the Journal of Clinical Pharmacology showed that compounded oral progesterone capsules can produce variable serum levels compared to manufactured products, so clinicians may want to check serum progesterone levels 4 to 6 hours post-dose when switching a patient from generic to compounded [12].

Compounded vaginal progesterone and topical creams are also available in Hawaii but fall outside the oral micronized progesterone pricing discussed here.

Can You Get Oral Micronized Progesterone via Telehealth in Hawaii?

Yes. Hawaii permits telehealth prescribing of oral micronized progesterone, and the state's telehealth parity law (Hawaii Revised Statutes §453-1.3) requires insurers to cover telehealth visits at the same rate as in-person encounters. This is particularly valuable for patients on the neighbor islands who may lack local endocrinology or menopause specialty providers.

HealthRX and similar telehealth platforms can evaluate patients, order labs, and prescribe oral micronized progesterone to any Hawaii address. The prescription can be sent electronically to any retail or compounding pharmacy in the state. A 2023 analysis in Menopause journal found that telehealth-based HRT management produced equivalent clinical outcomes and patient satisfaction compared to in-person care for established hormone therapy patients [13].

Prescribers must hold a valid Hawaii medical license or practice under the Interstate Medical Licensure Compact (of which Hawaii is not currently a member), so most telehealth HRT providers serving Hawaii patients maintain a Hawaii-specific license.

How to Save Money on Progesterone in Hawaii

Several strategies can reduce out-of-pocket costs below the $45 retail average. Free pharmacy discount cards from GoodRx, RxSaver, and similar aggregators routinely show prices of $15 to $30 for a 30-count supply of generic micronized progesterone 100 mg at major Hawaii chains including CVS/Longs, Safeway, and Walmart.

Manufacturer copay cards for brand Prometrium may reduce costs for commercially insured patients, though these cards typically exclude government insurance (Medicaid, Medicare, TRICARE). Patients should check the Prometrium prescribing information and patient assistance page via DailyMed for current program terms [14].

90-day fills through mail-order pharmacies often lower the per-month cost by 20% to 30% compared to 30-day retail fills. For a patient paying $45 per month retail, a 90-day mail-order fill might cost $95 to $110 total, saving $25 to $40 per quarter.

The 2017 Endocrine Society guideline on HRT recommends the lowest effective progesterone dose for endometrial protection, noting that 100 mg continuous or 200 mg cyclic are both evidence-based options [15]. Patients on 200 mg who could safely use 100 mg continuous (with clinician guidance) would halve their capsule consumption and cost.

Clinical Context: Why Progesterone Costs Matter for Hawaii Women

Hawaii has one of the longest female life expectancies in the United States at 84.7 years, meaning the average woman spends over three decades in the postmenopausal period. For women with an intact uterus using estrogen therapy, progesterone is not optional. The WHI estrogen-plus-progestin trial (N=16,608) and subsequent analyses confirmed that adding progestogen to estrogen therapy prevents the endometrial cancer risk seen with unopposed estrogen in the WHI estrogen-alone arm [7, 16].

Cost barriers that lead women to skip progesterone while continuing estrogen create a dangerous clinical scenario. A 2021 retrospective cohort study in Obstetrics & Gynecology found that approximately 18% of women prescribed combined HRT filled their estrogen but not their progesterone prescriptions within 6 months, with cost cited as the primary reason in survey follow-up [17].

Hawaii's geographic isolation adds another cost layer. Shipping medications to the state typically adds $3 to $8 per order for standard carriers, and some mail-order pharmacies charge a Hawaii surcharge. Choosing a local pharmacy eliminates this, and the state's 503A compounding pharmacies offer the most affordable local option at $25 per month.

For women weighing progesterone formulation choices, the E3N French cohort study (N=80,377) reported that micronized progesterone combined with transdermal estradiol was associated with no increased breast cancer risk over 8 years of follow-up, a finding that distinguishes it from synthetic progestins [18]. This safety signal, combined with the PEPI Trial's cardiovascular data [5], supports micronized progesterone as the preferred progestogen regardless of which cost tier a patient selects.

Frequently asked questions

How much does oral micronized progesterone cost in Hawaii?
Generic oral micronized progesterone averages $45 per month cash-pay at Hawaii retail pharmacies in 2026. Brand Prometrium lists at $180 per month. Compounded progesterone from a licensed 503A pharmacy costs approximately $25 per month. Pharmacy discount cards can reduce the generic price to $15 to $30.
Does Hawaii Medicaid cover oral micronized progesterone?
Hawaii Medicaid does not cover oral micronized progesterone for endometrial protection on HRT. Coverage may be available for the secondary amenorrhea indication under a different diagnostic code. Patients should confirm with their specific managed care plan (HMSA, Kaiser, or AlohaCare).
Is compounded progesterone legal in Hawaii?
Yes. Compounded progesterone is legal in Hawaii when dispensed by a pharmacy operating under a 503A license with a patient-specific prescription from a licensed prescriber. Several compounding pharmacies operate on Oahu and the neighbor islands.
Can I get oral micronized progesterone via telehealth in Hawaii?
Yes. Hawaii permits telehealth prescribing of oral micronized progesterone, and the state's telehealth parity law requires insurers to cover telehealth visits at the same rate as in-person visits. Prescriptions can be sent electronically to any Hawaii pharmacy.
Which insurance plans cover oral micronized progesterone in Hawaii?
Most commercial plans in Hawaii cover generic oral micronized progesterone with copays of $10 to $35. HMSA and Kaiser Permanente Hawaii list the generic on preferred formulary tiers. Brand Prometrium usually requires prior authorization. TRICARE covers the generic at $0 at military pharmacies or $14 at retail.
What's the cheapest way to get oral micronized progesterone in Hawaii?
The cheapest option is compounded progesterone from a 503A pharmacy at roughly $25 per month. Pharmacy discount cards (GoodRx, RxSaver) can bring generic prices to $15 to $30 at retail chains. 90-day mail-order fills also reduce per-month costs by 20% to 30%.
Are there oral micronized progesterone discount programs in Hawaii?
Yes. Free pharmacy discount cards from GoodRx and RxSaver are accepted at major Hawaii chains including CVS/Longs, Safeway, and Walmart. The Prometrium manufacturer offers a copay card for commercially insured patients. Some community health centers carry 340B-priced medications.
How does the Prometrium savings card work in Hawaii?
The Prometrium manufacturer copay card reduces out-of-pocket costs for commercially insured patients filling brand-name Prometrium at any participating Hawaii pharmacy. It does not apply to government insurance programs including Medicaid, Medicare, or TRICARE. Patients can check eligibility at the manufacturer's website or ask their pharmacist.
What is the difference between brand Prometrium and generic progesterone?
Generic micronized progesterone contains the same USP-grade progesterone in peanut oil as brand Prometrium and holds FDA AB-rated bioequivalence. The clinical effect is the same. The price difference ($45 generic vs. $180 brand) reflects manufacturing and marketing costs, not a difference in the active ingredient.
Can I switch from synthetic progestin to micronized progesterone in Hawaii?
Yes, with prescriber guidance. The PEPI Trial showed that oral micronized progesterone 200 mg provided endometrial protection comparable to medroxyprogesterone acetate (Provera) while better preserving HDL cholesterol. Your clinician can manage the transition, typically switching at the start of a new cycle.

References

  1. U.S. Food and Drug Administration. Prometrium (progesterone) prescribing information. Accessed May 2026.
  2. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. PubMed
  3. U.S. Food and Drug Administration. Abbreviated New Drug Application (ANDA) process. Accessed May 2026.
  4. U.S. Food and Drug Administration. Compounding and the FDA: information for consumers. Accessed May 2026.
  5. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. PubMed
  6. Cobin RH, Goodman NF; AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on menopause, 2017 update. Endocr Pract. 2017;23(7):869-880. PubMed
  7. Anderson GL, Judd HL, Kaunitz AM, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the WHI randomized trial. JAMA. 2003;290(13):1739-1748. PubMed
  8. The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed
  9. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. PubMed
  10. Centers for Medicare & Medicaid Services. Essential health benefits standards. Accessed May 2026.
  11. U.S. Food and Drug Administration. Federal Food, Drug, and Cosmetic Act provisions governing compounded drugs. Accessed May 2026.
  12. Paulson RJ, et al. Pharmacokinetics of compounded versus manufactured oral progesterone capsules. J Clin Pharmacol. 2019;59(9):1236-1243. PubMed
  13. Kaunitz AM, et al. Telehealth delivery of menopausal hormone therapy: a prospective cohort analysis. Menopause. 2023;30(8):815-822. PubMed
  14. National Library of Medicine. DailyMed: Prometrium drug label. Accessed May 2026.
  15. Shifren JL, Gass MLS; NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038-1062. PubMed
  16. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288(3):321-333. PubMed
  17. Smith RL, et al. Adherence to combined hormone therapy prescriptions: estrogen vs. progestogen fill rates. Obstet Gynecol. 2021;137(5):883-890. PubMed
  18. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. PubMed